Covalent reactions of Wortmannin under physiological conditions

被引:33
作者
Yuan, Hushan
Barnes, Katie R.
Weissleder, Ralph
Cantley, Lewis
Josephson, Lee
机构
[1] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
[3] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA
[4] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA
来源
CHEMISTRY & BIOLOGY | 2007年 / 14卷 / 03期
关键词
D O I
10.1016/j.chembiol.2007.02.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wortmannin (Wm), a steroid-like molecule of 428.4 Da, appears to be unstable in biological fluids (apparent chemical instability), yet it exhibits an anti proliferative activity in assays employing a 48 hr incubation period (prolonged bioactivity), a situation we refer to as the "wortmannin paradox." Under physiological conditions, Wm covalently reacts with nucleophiles such as the side chains of cysteine, N-methyl hexanoic acid, lysine, or proline at the C20 position on the furan ring. Like Wm, WmC20 amino acid derivatives had significant anti proliferative activities. Three Wm derivatives, WmC20-proline, WmC20-cysteine, and a WmC20-N-methyl hexanoic acid, generated Wm that then reacted with lysine in an exchange-type reaction. This unusual, reversible, covalent reaction of Wm with nucleophiles under physiological conditions provides an explanation for the wortmannin paradox.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 29 条
[21]   ANTIINFLAMMATORY ACTIVITY OF NEW MOLD METABOLITE 11-DEACETOXY-WORTMANNIN AND OF SOME OF ITS DERIVATIVES [J].
WIESINGE.D ;
GUBLER, HU ;
HAEFLIGE.W ;
HAUSER, D .
EXPERIENTIA, 1974, 30 (02) :135-136
[22]   Chemistry and biology of wortmannin [J].
Wipf, P ;
Halter, RJ .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2005, 3 (11) :2053-2061
[23]   Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin [J].
Wipf, P ;
Minion, DJ ;
Halter, RJ ;
Berggren, MI ;
Ho, CB ;
Chiang, GG ;
Kirkpatrick, L ;
Abraham, R ;
Powis, G .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (13) :1911-1920
[24]   Inhibiting the phosphoinositide 3-kinase pathway for cancer treatment [J].
Workman, P .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 :393-396
[25]   Phosphoinositide 3-kinase γ:: a key modulator in inflammation and allergy [J].
Wymann, MP ;
Björklöf, K ;
Calvez, R ;
Finan, P ;
Thomas, M ;
Trifilieff, A ;
Barbier, M ;
Altruda, F ;
Hirsch, E ;
Laffargue, M .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 :275-280
[26]  
Wymann MP, 1996, MOL CELL BIOL, V16, P1722
[27]   A cell-permeable, activity-based probe for protein and lipid kinases [J].
Yee, M ;
Fas, SC ;
Stohlmeyer, MM ;
Wandless, TJ ;
Cimprich, KA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (32) :29053-29059
[28]   Wortmannin-C20 conjugates generate wortmannin [J].
Yuan, HS ;
Luo, J ;
Weissleder, R ;
Cantley, L ;
Josephson, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :740-747
[29]   Pegylated wortmannin and 17-hydroxywortmannin conjugates as phosphoinositide 3-kinase inhibitors active in human tumor xenograft models [J].
Zhu, TM ;
Gu, JX ;
Yu, K ;
Lucas, J ;
Cai, P ;
Tsao, R ;
Gong, YM ;
Li, FB ;
Chaudhary, I ;
Desai, P ;
Ruppen, M ;
Fawzi, M ;
Gibbons, J ;
Ayral-Kaloustian, S ;
Skotnicki, J ;
Mansour, T ;
Zask, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (04) :1373-1378